Large CapHealthcareDividend

CAH Cardinal Health, Inc.

Healthcare Distributors · Founded 1971 · Dublin, Ohio · CEO: Jason Hollar

Cardinal Health is one of the three dominant U.S. pharmaceutical distributors and a major medical products company. Its pharmaceutical distribution segment provides drug logistics to health systems, retail pharmacies, and mail-order pharmacies. Its GMPD (Global Medical Products and Distribution) segment manufactures and distributes surgical supplies, exam gloves, and medical-surgical products. Cardinal Health spun off its specialty pharmaceutical distributor Specialty Networks and has been restructuring its medical products business to improve profitability.

How Cardinal Health, Inc. Makes Money

1

Pharmaceutical segment distribution fees and spread on drug wholesale distribution

2

GMPD segment revenue from manufacture and sale of branded and private-label medical products

3

Nuclear and precision health (Lantheus / Cardinal Health Specialty) radiopharmaceutical distribution

4

Services and other revenue from clinical intelligence solutions

#

Key Metrics Investors Watch

  • Pharmaceutical segment profit growth and distribution fee retention
  • GMPD segment margin recovery and improvement trajectory
  • Specialty pharmaceutical business revenue
  • Free cash flow and return to shareholders
  • Debt management and leverage ratios
+

Competitive Advantages

  • Cardinal Health nuclear pharmacy network distributes radiopharmaceuticals to hospitals daily
  • Medical products manufacturing capability provides differentiation beyond pure distribution
  • Scale and customer relationships across health systems and retail pharmacies create switching costs
  • Downstream distribution integration reduces supply chain complexity for hospital customers
!

Key Risks

  • Medical segment profitability has been under pressure from inflation and supply chain disruptions
  • Pharmaceutical distribution margins face ongoing pressure from large customer negotiations
  • Opioid settlement liability remains a legacy expense
  • Competition from McKesson and Cencora across all major distribution lines
$

Dividend & Capital Return

Cardinal Health is a Dividend Aristocrat with decades of consecutive dividend increases, reflecting the company's historically consistent cash generation.

I Document Every Trade — Even the Losses

Options record: 1W-8L. Net worth: 100% GSE preferred. Get the unfiltered updates.

Unsubscribe anytime. I respect your inbox more than Congress respects property rights.

Frequently Asked Questions

What makes Cardinal Health different from McKesson?

Cardinal Health has a medical products manufacturing and distribution segment that gives it capabilities beyond pure drug distribution. Its nuclear pharmacy network is a specialized high-margin business. McKesson has its US Oncology Network practice management business as its key differentiator. This is educational content, not financial advice.

What is Cardinal Health's nuclear pharmacy business?

Cardinal Health operates the largest nuclear pharmacy network in the U.S., compounding and distributing radiopharmaceuticals (radioactive drugs used in PET scans and cancer treatment) to hospitals daily. These products have very short half-lives requiring delivery within hours of production. This is educational content, not financial advice.

Is Cardinal Health a Dividend Aristocrat?

Yes, Cardinal Health has increased its dividend for over 25 consecutive years, qualifying it as a Dividend Aristocrat. Its stable distribution business generates predictable cash flows supporting this streak. This is educational content, not financial advice.

Does Cardinal Health pay a dividend?

Yes, Cardinal Health is a Dividend Aristocrat with over 25 consecutive years of dividend increases, supported by the steady cash generation of its pharmaceutical distribution business. This is educational content, not financial advice.

What challenges has Cardinal Health's medical segment faced?

Cardinal Health's GMPD medical products segment experienced significant margin compression from supply chain inflation, PPE pricing normalization post-COVID, and operational inefficiencies. Management has been undertaking a multi-year profitability improvement program. This is educational content, not financial advice.

Related Stocks

UNH

UnitedHealth Group Incorporated

Healthcare

UnitedHealth Group is the largest health insurance company in the US, serving tens of millions of members through UnitedHealthcare. The company also operates Optum, a diversified health services platform spanning pharmacy benefits, care delivery, and health technology.

CVS

CVS Health Corporation

Healthcare

CVS Health is a vertically integrated healthcare company operating pharmacy benefit management (Caremark), retail pharmacies (9,000+ stores), health insurance (Aetna), and clinic-based care (MinuteClinic, Oak Street Health). The 2018 acquisition of Aetna for $69 billion transformed CVS from a pharmacy chain into a healthcare ecosystem player. CVS manages prescription drug benefits for tens of millions of Americans through Caremark and continues to expand primary care through Oak Street Health, acquired in 2023.

HUM

Humana Inc.

Healthcare

Humana is one of the largest health insurance companies in the United States with a dominant position in Medicare Advantage, the privately managed version of Medicare. Humana serves over 5 million Medicare Advantage members and benefits from the secular trend of Baby Boomers aging into Medicare eligibility. The company is heavily focused on value-based care through its CenterWell (formerly Conviva) primary care clinic network and home health services. Humana's earnings are highly sensitive to Medicare Advantage reimbursement rates set by CMS.

MCK

McKesson Corporation

Healthcare

McKesson is one of the three dominant U.S. pharmaceutical distributors alongside AmerisourceBergen (Cencora) and Cardinal Health, distributing branded and generic drugs, medical supplies, and specialty pharmaceuticals to pharmacies, hospitals, and clinics. As a distributor, McKesson's margins are thin but volumes are enormous. The company also operates oncology specialty distribution and has a growing presence in oncology practice management through The US Oncology Network.

ABC

Cencora, Inc.

Healthcare

Cencora (formerly AmerisourceBergen, rebranded in 2023) is one of the three dominant U.S. pharmaceutical distributors, ranking alongside McKesson and Cardinal Health. The company distributes specialty and traditional pharmaceuticals to community pharmacies, health systems, and physician offices. Cencora has a particularly strong position in specialty drug distribution through its AmerisourceBergen Drug Corporation and World Courier specialty logistics operations. Strategic partnerships with Walgreens Boots Alliance give Cencora significant volume and distribution advantage.

Recommended Resources

Tools & books I actually use and recommend

SeekingAlpha Premium

Quant ratings, earnings transcripts, and the stock analysis community where I published 300+ articles.

Try SeekingAlpha

The Intelligent Investor

Ben Graham's timeless guide to value investing. The book Warren Buffett calls "the best investing book ever written."

View on Amazon

Interactive Brokers

Low commissions, global market access, and professional-grade tools. This is where I hold my positions.

Open an Account

Some links above are affiliate links. I only recommend products I personally use. See my full disclosures.

Browse All 134 Stock Profiles

Company information is based on publicly available disclosures and widely-known business facts. No specific price, earnings, or real-time market data is included. This is educational content — not investment advice.